altimmune.com
Open in
urlscan Pro
2001:19f0:5:3d77:5400:4ff:fe90:9b9c
Public Scan
Submitted URL: http://altimmune.com/
Effective URL: https://altimmune.com/
Submission: On September 21 via manual from US — Scanned from DE
Effective URL: https://altimmune.com/
Submission: On September 21 via manual from US — Scanned from DE
Form analysis
0 forms found in the DOMText Content
Skip to main content Menu * ABOUT US * COMPANY OVERVIEW * EXECUTIVE TEAM * SENIOR LEADERSHIP TEAM * BOARD OF DIRECTORS * SCIENTIFIC ADVISORY BOARDS * PARTNERSHIPS * PIPELINE * OUR PIPELINE * Pemvidutide * HepTcell™ * INVESTORS * OVERVIEW * PRESS RELEASES * PRESS RELEASES * PHARMATHENE, INC. HISTORICAL PRESS RELEASES * IN THE NEWS * EVENTS AND PRESENTATIONS * STOCK INFORMATION * STOCK QUOTE & CHART * HISTORICAL PRICE LOOKUP * INVESTMENT CALCULATOR * ANALYST COVERAGE * GOVERNANCE * DOCUMENTS & CHARTERS * MANAGEMENT TEAM * BOARD OF DIRECTORS * COMMITTEE COMPOSITION * FINANCIALS * SEC FILINGS * INVESTOR RESOURCES * INVESTOR FAQS * IR CONTACT * EMAIL ALERTS * CLINICAL TRIALS * JOIN TRIAL * CAREERS * CONTACT US JOIN OUR MOMENTUM TRIAL OUR FOCUS DEVELOPING NEXT GENERATION PEPTIDE THERAPEUTICS FOR OBESITY AND LIVER DISEASE OUR PROGRAMS We are a clinical stage biopharmaceutical company developing peptide-based therapeutics: * Pemvidutide for obesity * Pemvidutide for non-alcoholic steatohepatitis (NASH) * HepTcell™ for chronic hepatitis B VIEW PIPELINE 910 Clopper Road Suite 201-S Gaithersburg, MD 20878 (240) 654-1450 ALTIMMUNE * About Us * Pipeline * Clinical Trials * Partnerships * Careers * Contact Us * Terms & Conditions * Privacy Policy PIPELINE * Our Pipeline * Pemvidutide * HepTcell™ INVESTORS * Overview * Press Releases * In The News * Events & Presentations * Stock Information * Analyst Coverage * Governance * Financials * Investor Resources © 2023 Altimmune Website. All rights reserved. * LinkedIn * ABOUT US * COMPANY OVERVIEW * EXECUTIVE TEAM * SENIOR LEADERSHIP TEAM * BOARD OF DIRECTORS * SCIENTIFIC ADVISORY BOARDS * PARTNERSHIPS * PIPELINE * OUR PIPELINE * Pemvidutide * HepTcell™ * INVESTORS * OVERVIEW * PRESS RELEASES * PRESS RELEASES * PHARMATHENE, INC. HISTORICAL PRESS RELEASES * IN THE NEWS * EVENTS AND PRESENTATIONS * STOCK INFORMATION * STOCK QUOTE & CHART * HISTORICAL PRICE LOOKUP * INVESTMENT CALCULATOR * ANALYST COVERAGE * GOVERNANCE * DOCUMENTS & CHARTERS * MANAGEMENT TEAM * BOARD OF DIRECTORS * COMMITTEE COMPOSITION * FINANCIALS * SEC FILINGS * INVESTOR RESOURCES * INVESTOR FAQS * IR CONTACT * EMAIL ALERTS * CLINICAL TRIALS * JOIN TRIAL * CAREERS * CONTACT US Close Menu